IL1B and rheumatoid arthritis: It is widely known that pro‐inflammatory cytokines, such as TNF‐α and IL‐1β, play a role in the pathophysiology of RA to the extent that a number of therapies have been designed to solely target these cytokines (Brennan & McInnes, 2008; Dayer, 2003).